We raised our Broadcom price target after a stock pop that was all about the conference call
Broadcom on Thursday evening reported a strong quarter and a solid guide. But the stock really got going…
Salesforce’s soft guidance gives the skeptics more fuel. Here’s why we are hanging on
Salesforce on Wednesday reported better-than-expected second quarter results, but the stock sold off in extended trading due to…
7 portfolio stocks that stand to benefit most from Fed rate cuts
Federal Reserve interest rate cuts are a boon to all stocks. But they are especially beneficial to certain…
10 things to watch in the stock market Friday including Dell and Marvell earnings
The Club’s 10 things to watch Friday, Aug. 29 — Today’s newsletter was written by Jeff Marks, the…
Jim Cramer says faith in growth stocks like Nvidia pays off
CNBC’s Jim Cramer on Thursday explained why he encourages investors to have faith in good growth stocks and…
The rewards and risks of Amazon’s push to add fresh groceries to same-day delivery
Amazon is rewriting the playbook for grocery delivery. The company’s new push to add fresh groceries to its…
Nvidia shares fall on a strong but not impenetrable quarter. There’s still so much to like
Nvidia delivered a better-than-expected quarterly results Wednesday night, but a few blemishes in the report — at least…
The ripple effect of Nvidia, plus an analyst turns bullish on Amazon
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
All eyes on Nvidia’s earnings report heading into the market close
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
10 things to watch in the stock market Friday including the Fed and Nvidia’s China plans
The Club’s 10 things to watch Friday, Aug. 22 — Today’s newsletter was written by Portfolio Analyst Zev…
How this week’s market upended what Fed rate cuts mean for tech stocks
Friday is Fed Day. That’s when Federal Reserve Chairman Jerome Powell will address the central bank’s annual economic…
We’re downgrading Lilly and asking ourselves tough questions after its obesity pill letdown
Eli Lilly delivered strong second-quarter results on Thursday, but shares are plummeting because of disappointing data for a…